References
1. COVID Data Tracker. CDC; 2021.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home.
2. American Academy of Pediatrics CsHA. Children and COVID-19:
State-Level Data Report. 2021. Accessed June 23, 2021.
3. Zimmermann P, Curtis N. Coronavirus Infections in Children Including
COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis,
Treatment and Prevention Options in Children. The Pediatric
infectious disease journal. 2020;39(5):355-368.
4. Yelin D, Wirtheim E, Vetter P, et al. Long-term consequences of
COVID-19: research needs. The Lancet Infectious Diseases.2020;20(10):1115-1117.
5. Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After
Acute COVID-19. Jama. 2020;324(6):603-605.
6. Abdallah SJ VN, Corrales-Medina VF, McGuinty M, Pratt A, Chopra A,
Law A, Garuba HA, Thavorn K, Reid RER, Lavoie KL, Crawley A, Chirinos
JA, Cowan J. Symptoms, Pulmonary Function and Functional Capacity Four
Months after COVID-19. Annals of the American Thoracic Society.2021.
7. Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in
patients discharged from hospital: a cohort study. The Lancet.2021;397(10270):220-232.
8. Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in Adults at 6
Months After COVID-19 Infection. JAMA Network Open.2021;4(2):e210830-e210830.
9. Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the
Faroe Islands - a longitudinal study among non-hospitalized patients.Clinical infectious diseases : an official publication of the
Infectious Diseases Society of America. 2020.
10. Tenforde MW KS, Lindsell CJ, et al. Symptom Duration and Risk
Factors for Delayed Return to Usual Health Among Outpatients with
COVID-19 in a Multistate Health Care Systems Network — United States,
March–June 2020. MMWR and Morbidity and Mortality Weekly Report.2020;69:993-998.
11. Morin L, Savale L, Pham T, et al. Four-Month Clinical Status of a
Cohort of Patients After Hospitalization for COVID-19. Jama.2021;325(15):1525-1534.
12. Excellence NIfHaC. COVID-19 rapid guideline: managing the
long-term effects of COVID-19. London: National Institute for Health
and Care Excellence (UK); December 18, 2020 2020.
13. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for
spirometry across all ages: a new approach. Am J Respir Crit Care
Med. 2008;177(3):253-260.
14. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of
spirometry. The European respiratory journal. 2005;26(2):319-338.
15. ATS Statement: Guidelines for the Six-Minute Walk Test.American Journal of Respiratory and Critical Care Medicine.2002;166(1):111-117.
16. Townsend L, Dowds J, O’Brien K, et al. Persistent Poor Health after
COVID-19 Is Not Associated with Respiratory Complications or Initial
Disease Severity. Ann Am Thorac Soc. 2021;18(6):997-1003.
17. National Current Asthma Prevalence. CDC; 2019.
https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm.
18. Robbins JM, Mallya G, Wagner A, Buehler JW. Prevalence, Disparities,
and Trends in Obesity and Severe Obesity Among Students in the School
District of Philadelphia, Pennsylvania, 2006-2013. Preventing
chronic disease. 2015;12:E134.
19. Salman D, Vishnubala D, Le Feuvre P, et al. Returning to physical
activity after covid-19. BMJ. 2021;372:m4721.
20. Arnold D, Milne A, Samms E, Stadon L, Maskell N, Hamilton F. Are
vaccines safe in patients with Long COVID? A prospective observational
study. medRxiv. 2021:2021.2003.2011.21253225.